Simon Pedder

Directeur Général chez Nirogy Therapeutics, Inc.

Profil

Simon C.
Pedder founded Chelsea Therapeutics International Ltd.
in 2005, where he worked as President, Chief Executive Officer & Director from 2005 to 2012.
Dr. Pedder also currently works at Nirogy Therapeutics, Inc., as Chief Executive Officer from 2022, Eboo Pharmaceuticals, Inc., as Director, Ballantyne Therapeutics, Inc., as Director, and Atlantic Research Group, Inc., as Director.
Dr. Pedder also formerly worked at Ivory Capital Corp., as President & Chief Executive Officer from 2004 to 2005, Chelsea Therapeutics, Inc., as President & Chief Executive Officer from 2004 to 2012, Novelos Therapeutics, Inc., as Chief Executive Officer & Director from 2013 to 2014, Cellectar Biosciences, Inc., as President, Chief Executive Officer & Director from 2014 to 2015, Oncotelic Therapeutics, Inc., as Independent Director from 2016 to 2019, Delcath Systems, Inc., as Independent Director from 2017 to 2019, Avalo Therapeutics, Inc., as President & Director in 2020, Oncology Pharma, Inc., as Vice President, Athenex, Inc., as Chief Business & Strategy Officer-Proprietary, Hoffmann-La Roche, Inc., as Vice President-Pharmaceutical Business & Oncology, Shearwater Corp., as Vice President-Drug Development from 2001 to 2002, and the University of Saskatchewan College of Medicine, as Member.
Dr. Pedder received his graduate degree from Concordia University, undergraduate degree from The University of Waterloo, and doctorate degree from the University of Saskatchewan College of Medicine.

Postes actifs de Simon Pedder

Sociétés	Poste	Début
Eboo Pharmaceuticals, Inc.	Directeur/Membre du Conseil	-
Ballantyne Therapeutics, Inc.	Directeur/Membre du Conseil	-
Atlantic Research Group, Inc.	Directeur/Membre du Conseil	-
Nirogy Therapeutics, Inc.	Directeur Général	12/01/2022

Anciens postes connus de Simon Pedder

Sociétés	Poste	Fin
ATHENEXPAR	Corporate Officer/Principal	31/12/2021
AVALO THERAPEUTICS, INC.	Président	24/04/2020
ONCOTELIC THERAPEUTICS, INC.	Directeur/Membre du Conseil	10/04/2019
DELCATH SYSTEMS, INC.	Directeur/Membre du Conseil	10/04/2019
CELLECTAR BIOSCIENCES, INC.	Directeur Général	15/06/2015

Formation de Simon Pedder

Concordia University	Graduate Degree
The University of Waterloo	Undergraduate Degree
University of Saskatchewan College of Medicine	Doctorate Degree